These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18712752)

  • 1. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.
    Cormode DP; Briley-Saebo KC; Mulder WJ; Aguinaldo JG; Barazza A; Ma Y; Fisher EA; Fayad ZA
    Small; 2008 Sep; 4(9):1437-44. PubMed ID: 18712752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques.
    Burtea C; Laurent S; Lancelot E; Ballet S; Murariu O; Rousseaux O; Port M; Vander Elst L; Corot C; Muller RN
    Mol Pharm; 2009; 6(6):1903-19. PubMed ID: 19743879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of apolipoprotein A-I mimetics.
    Mendez AJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):171-6. PubMed ID: 20125002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-/- mice: a pilot study.
    Alsaid H; De Souza G; Bourdillon MC; Chaubet F; Sulaiman A; Desbleds-Mansard C; Chaabane L; Zahir C; Lancelot E; Rousseaux O; Corot C; Douek P; Briguet A; Letourneur D; Canet-Soulas E
    Invest Radiol; 2009 Mar; 44(3):151-8. PubMed ID: 19169144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
    Ibanez B; Vilahur G; Cimmino G; Speidl WS; Pinero A; Choi BG; Zafar MU; Santos-Gallego CG; Krause B; Badimon L; Fuster V; Badimon JJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1104-9. PubMed ID: 18342230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
    Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action.
    Getz GS; Wool GD; Reardon CA
    Curr Opin Lipidol; 2009 Jun; 20(3):171-5. PubMed ID: 19373084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis.
    Marrache S; Dhar S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9445-50. PubMed ID: 23671083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging.
    Parolini C; Marchesi M; Lorenzon P; Castano M; Balconi E; Miragoli L; Chaabane L; Morisetti A; Lorusso V; Martin BJ; Bisgaier CL; Krause B; Newton RS; Sirtori CR; Chiesa G
    J Am Coll Cardiol; 2008 Mar; 51(11):1098-103. PubMed ID: 18342229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.
    Waldeck J; Häger F; Höltke C; Lanckohr C; von Wallbrunn A; Torsello G; Heindel W; Theilmeier G; Schäfers M; Bremer C
    J Nucl Med; 2008 Nov; 49(11):1845-51. PubMed ID: 18927332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques.
    Wilensky RL; Song HK; Ferrari VA
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C48-56. PubMed ID: 16631510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging.
    Lipinski MJ; Fuster V; Fisher EA; Fayad ZA
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):48-55. PubMed ID: 16265260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
    Cormode DP; Chandrasekar R; Delshad A; Briley-Saebo KC; Calcagno C; Barazza A; Mulder WJ; Fisher EA; Fayad ZA
    Bioconjug Chem; 2009 May; 20(5):937-43. PubMed ID: 19378935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease.
    Liu XS; Xu JR
    Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL mimetic CER-001 targets atherosclerotic plaques in patients.
    Zheng KH; van der Valk FM; Smits LP; Sandberg M; Dasseux JL; Baron R; Barbaras R; Keyserling C; Coolen BF; Nederveen AJ; Verberne HJ; Nell TE; Vugts DJ; Duivenvoorden R; Fayad ZA; Mulder WJM; van Dongen GAMS; Stroes ESG
    Atherosclerosis; 2016 Aug; 251():381-388. PubMed ID: 27263077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging by cardiovascular MR.
    Cyrus T; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(6):827-43. PubMed ID: 18066742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.